IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: A randomised open label study for the treatment of HIV-1 infection

RepositoryUniversity of Queensland [UQ eSpace]
URLhttps://espace.library.uq.edu.au/view/UQ:512223
Author(s)Amin, Janaki; Boyd, Mark A.; Kumarasamy, Nagalingeswaran; Moore, Cecilia L.; Losso, Marcello H.; Nwizu, Chidi A.; Mohapi, Lerato; Kerr, Stephen J.; Sohn, Annette H.; Teppler, Hedy; Renjifo, Boris; Molina, Jean-Michel; Emery, Sean; Cooper, David A.
Item typeArticle
DOIhttps://doi.org/10.1371/journal.pone.0118228

Usage Date Range

Note: Daily statistics are only available for the last six weeks.

     

Country Reporting Period Total 2021-12-17 2021-12-18 2021-12-19 2021-12-20 2021-12-21 2021-12-22
Overall totals 2 1 0 0 0 0 1
United States 2 1 0 0 0 0 1
Jisc logo Cranfield logo CAVAL logo